Origin, Diversity, and Multiple Roles of Enzymes with Metallo-β-Lactamase Fold from Different Organisms.

antibiotic-hydrolysing activity domains of life lactonase metallo-β-lactamase (MβL) fold proteins multifunctional enzymes nuclease ribonuclease

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
30 Jun 2023
Historique:
received: 11 05 2023
revised: 23 06 2023
accepted: 28 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

β-lactamase enzymes have generated significant interest due to their ability to confer resistance to the most commonly used family of antibiotics in human medicine. Among these enzymes, the class B β-lactamases are members of a superfamily of metallo-β-lactamase (MβL) fold proteins which are characterised by conserved motifs (i.e., HxHxDH) and are not only limited to bacteria. Indeed, as the result of several barriers, including low sequence similarity, default protein annotation, or untested enzymatic activity, MβL fold proteins have long been unexplored in other organisms. However, thanks to search approaches which are more sensitive compared to classical Blast analysis, such as the use of common ancestors to identify distant homologous sequences, we are now able to highlight their presence in different organisms including Bacteria, Archaea, Nanoarchaeota, Asgard, Humans, Giant viruses, and Candidate Phyla Radiation (CPR). These MβL fold proteins are multifunctional enzymes with diverse enzymatic or non-enzymatic activities of which, at least thirteen activities have been reported such as β-lactamase, ribonuclease, nuclease, glyoxalase, lactonase, phytase, ascorbic acid degradation, anti-cancer drug degradation, or membrane transport. In this review, we (i) discuss the existence of MβL fold enzymes in the different domains of life, (ii) present more suitable approaches to better investigating their homologous sequences in unsuspected sources, and (iii) report described MβL fold enzymes with demonstrated enzymatic or non-enzymatic activities.

Identifiants

pubmed: 37443786
pii: cells12131752
doi: 10.3390/cells12131752
pmc: PMC10340364
pii:
doi:

Substances chimiques

beta-Lactamases EC 3.5.2.6
Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Méditerranée Infection Foundation
ID : 10-IAHU-03

Références

FEBS Lett. 2001 Aug 10;503(1):1-6
pubmed: 11513844
Protein Eng Des Sel. 2021 Feb 15;34:
pubmed: 34100551
Antimicrob Agents Chemother. 2005 Jul;49(7):2778-84
pubmed: 15980349
Acta Crystallogr F Struct Biol Commun. 2017 Aug 01;73(Pt 8):476-480
pubmed: 28777091
RNA Biol. 2011 Nov-Dec;8(6):1073-83
pubmed: 21955587
Life (Basel). 2020 Nov 14;10(11):
pubmed: 33202677
Crit Rev Microbiol. 2016;42(1):17-30
pubmed: 24495094
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30061284
Nucleic Acids Res. 2016 Feb 29;44(4):1813-32
pubmed: 26826708
Lett Appl Microbiol. 2014 Dec;59(6):615-20
pubmed: 25146240
Antimicrob Agents Chemother. 2014;58(1):212-20
pubmed: 24145532
Mol Cell Biol. 2000 Jul;20(13):4553-61
pubmed: 10848582
Mol Biol Evol. 2013 Feb;30(2):369-83
pubmed: 23071100
J Antimicrob Chemother. 2011 Sep;66(9):2038-44
pubmed: 21680581
J Struct Biol. 2011 Jan;173(1):191-5
pubmed: 20851187
Methods Cell Biol. 2007;79:169-91
pubmed: 17327157
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11882-7
pubmed: 16087890
NPJ Biofilms Microbiomes. 2021 Apr 22;7(1):40
pubmed: 33888726
Mol Cell Biol. 2004 Dec;24(24):10733-41
pubmed: 15572677
Trends Biochem Sci. 2016 Apr;41(4):338-355
pubmed: 26805042
Pers Soc Psychol Bull. 2005 Jan;31(1):63-72
pubmed: 15574662
mSystems. 2021 Dec 21;6(6):e0089821
pubmed: 34874773
Biochemistry. 2009 Nov 3;48(43):10298-307
pubmed: 19788310
Proteins. 2010 Aug 1;78(10):2399-402
pubmed: 20544975
J Am Chem Soc. 2013 Feb 27;135(8):2899-902
pubmed: 23394108
Genome Biol Evol. 2014 Jun 13;6(7):1603-10
pubmed: 24929085
Emerg Microbes Infect. 2019;8(1):1688-1700
pubmed: 31749408
mSphere. 2019 Jun 19;4(3):
pubmed: 31217298
Appl Environ Microbiol. 2012 Nov;78(22):7985-92
pubmed: 22941089
Nat Commun. 2015 Feb 27;6:6372
pubmed: 25721682
J Sci Food Agric. 2015 Mar 30;95(5):878-96
pubmed: 25382707
PLoS Comput Biol. 2009 Dec;5(12):e1000605
pubmed: 20011109
Nucleic Acids Res. 2015 Dec 15;43(22):11047-60
pubmed: 26582912
Sci Rep. 2018 Jul 26;8(1):11262
pubmed: 30050039
Protein Sci. 2014 Oct;23(10):1442-50
pubmed: 25066955
Curr Protein Pept Sci. 2017;19(2):130-144
pubmed: 28745223
Extremophiles. 2012 Mar;16(2):333-43
pubmed: 22350204
Acta Crystallogr F Struct Biol Commun. 2016 Sep;72(Pt 9):681-6
pubmed: 27599858
Int J Mol Sci. 2022 May 13;23(10):
pubmed: 35628255
Appl Environ Microbiol. 2010 Apr;76(8):2524-30
pubmed: 20173075
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21848-53
pubmed: 20007369
J Mol Biol. 2010 May 21;398(5):715-29
pubmed: 20359483
J Biochem. 2017 Feb 1;161(2):167-186
pubmed: 28175318
Intensive Care Med. 1994 Jul;20 Suppl 3:S5-9
pubmed: 7962990
Ann N Y Acad Sci. 2013 Jan;1277:91-104
pubmed: 23163348
J Biol Chem. 2005 Dec 9;280(49):40668-75
pubmed: 16227621
J Bacteriol. 2006 Feb;188(4):1607-14
pubmed: 16452444
PLoS One. 2016 May 23;11(5):e0155905
pubmed: 27214294
EMBO J. 1995 Oct 16;14(20):4914-21
pubmed: 7588620
Microbiology (Reading). 2003 Jun;149(Pt 6):1541-1550
pubmed: 12777494
Biochemistry. 2007 Oct 23;46(42):11789-99
pubmed: 17900178
Mar Drugs. 2018 Oct 08;16(10):
pubmed: 30297643
Appl Microbiol Biotechnol. 2011 Dec;92(5):921-8
pubmed: 22012341
RNA Biol. 2010 May-Jun;7(3):316-21
pubmed: 20458164
J Glob Antimicrob Resist. 2018 Sep;14:302-305
pubmed: 29842976
BMC Bioinformatics. 2010 Aug 18;11:431
pubmed: 20718988
Nat Rev Genet. 2004 May;5(5):366-75
pubmed: 15143319
Immunol Cell Biol. 2010 Nov-Dec;88(8):851-6
pubmed: 20458337
Sci Rep. 2020 Dec 10;10(1):21685
pubmed: 33303919
Nature. 2020 Jan;577(7791):519-525
pubmed: 31942073
Commun Biol. 2021 Jan 29;4(1):132
pubmed: 33514861
PLoS One. 2009;4(2):e4345
pubmed: 19190775
Antimicrob Agents Chemother. 2006 Apr;50(4):1123-9
pubmed: 16569819
Nat Chem Biol. 2018 Jun;14(6):556-564
pubmed: 29713061
Genome Biol Evol. 2018 Apr 1;10(4):1106-1114
pubmed: 29672703
J Mol Biol. 2014 Jun 26;426(13):2442-56
pubmed: 24769192
Nat Microbiol. 2016 Apr 11;1:16048
pubmed: 27572647
Int J Mol Sci. 2021 Aug 29;22(17):
pubmed: 34502284
Nature. 2015 Jul 9;523(7559):208-11
pubmed: 26083755
Cell Mol Life Sci. 2004 Nov;61(22):2827-39
pubmed: 15558212
Nucleic Acids Res. 2013 Jan;41(Database issue):D348-52
pubmed: 23197659
J Biochem. 2006 Oct;140(4):535-42
pubmed: 16945939
Sci Rep. 2019 Aug 21;9(1):12173
pubmed: 31434986
Biochem J. 1966 Jan;98(1):11C-3C
pubmed: 4957174
Crit Rev Biochem Mol Biol. 2007 Mar-Apr;42(2):67-93
pubmed: 17453916
Appl Environ Microbiol. 2018 Aug 31;84(18):
pubmed: 30006399
PLoS One. 2020 Oct 30;15(10):e0241557
pubmed: 33126240
Sci Rep. 2021 May 12;11(1):10062
pubmed: 33980996
J Mol Evol. 2011 Jan;72(1):14-33
pubmed: 21082171
Biochem Pharmacol. 2007 Dec 15;74(12):1686-701
pubmed: 17597585
Appl Environ Microbiol. 2015 Jan;81(2):774-82
pubmed: 25398866
J Infect Chemother. 2013 Aug;19(4):549-59
pubmed: 23828655
In Silico Biol. 1999;1(2):69-91
pubmed: 11471246

Auteurs

Seydina M Diene (SM)

MEPHI, IRD, AP-HM, IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France.
IHU-Méditerranée Infection, 13005 Marseille, France.

Pierre Pontarotti (P)

MEPHI, IRD, AP-HM, IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France.
IHU-Méditerranée Infection, 13005 Marseille, France.
CNRS SNC5039, 13005 Marseille, France.

Saïd Azza (S)

IHU-Méditerranée Infection, 13005 Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), IHU-Méditerranée Infection, 13005 Marseille, France.

Nicholas Armstrong (N)

IHU-Méditerranée Infection, 13005 Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), IHU-Méditerranée Infection, 13005 Marseille, France.

Lucile Pinault (L)

IHU-Méditerranée Infection, 13005 Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), IHU-Méditerranée Infection, 13005 Marseille, France.

Eric Chabrière (E)

MEPHI, IRD, AP-HM, IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France.
IHU-Méditerranée Infection, 13005 Marseille, France.

Philippe Colson (P)

MEPHI, IRD, AP-HM, IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France.
IHU-Méditerranée Infection, 13005 Marseille, France.

Jean-Marc Rolain (JM)

MEPHI, IRD, AP-HM, IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France.
IHU-Méditerranée Infection, 13005 Marseille, France.

Didier Raoult (D)

IHU-Méditerranée Infection, 13005 Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH